指南与共识临床试验与 GCP医学人工智能与信息学

人工智能干预临床试验方案报告指南:SPIRIT-AI扩展

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.
指南 / 共识 · BMJ · 2020-09-09

SPIRIT-AI扩展是面向评估含人工智能(AI)干预的临床试验方案的新报告指南,与CONSORT-AI并行制定。其通过文献回顾、专家咨询产生26个候选条目,经103名利益相关者两轮德尔菲调查、31人共识会议及34人清单试点后,最终纳入15个新条目,建议在SPIRIT 2013核心条目基础上常规报告。

要点

  • SPIRIT-AI扩展新增15个条目,用于AI干预临床试验方案报告。
  • 应清晰描述AI干预、使用说明与技能要求及整合场景。
  • 需报告输入输出数据处理、人机交互及错误案例分析。

核心结论

  • SPIRIT-AI扩展有助于提升AI干预临床试验方案的透明度和完整性。
  • 其可帮助编辑、同行评审和读者理解并批判性评估计划中的临床试验设计与偏倚风险。

研究设计与样本

  • SPIRIT-AI扩展采用分阶段共识流程制定,与CONSORT-AI并行开发。
  • 流程包括文献回顾和专家咨询以产生26个候选条目。
  • 由国际多利益相关方组进行两轮德尔菲调查(103名利益相关者)。
  • 经共识会议(31名利益相关者)达成一致,并通过清单试点(34名参与者)完善。

主要发现

  • SPIRIT-AI扩展包含15个被认为对AI干预临床试验方案足够重要的新条目。
  • 这些新条目应在SPIRIT 2013核心条目之外常规报告。

关键数值与推荐

  • SPIRIT-AI建议研究者清晰描述AI干预,包括使用所需的说明和技能。
  • 应描述AI干预将整合的场景。
  • 应考虑输入和输出数据的处理。
  • 应报告人机交互和错误案例分析。

临床怎么用

  • 研究者在撰写AI干预临床试验方案时,应在SPIRIT 2013核心条目基础上常规报告SPIRIT-AI的15个新条目。
  • 编辑和同行评审可使用该指南评估AI临床试验方案的报告完整性与设计偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The SPIRIT 2013 (The Standard Protocol Items: Recommendations for Interventional Trials) statement aims to improve the completeness of clinical trial protocol reporting, by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there is a growing recognition that interventions involving artificial intelligence need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes.The SPIRIT-AI extension is a new reporting guideline for clinical trials protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI. Both guidelines were developed using a staged consensus process, involving a literature review and expert consultation to generate 26 candidate items, which were consulted on by an international multi-stakeholder group in a 2-stage Delphi survey (103 stakeholders), agreed on in a consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants).The SPIRIT-AI extension includes 15 new items, which were considered sufficiently important for clinical trial protocols of AI interventions. These new items should be routinely reported in addition to the core SPIRIT 2013 items. SPIRIT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention will be integrated, considerations around the handling of input and output data, the human-AI interaction and analysis of error cases.SPIRIT-AI will help promote transparency and completeness for clinical trial protocols for AI interventions. Its use will assist editors and peer-reviewers, as well as the general readership, to understand, interpret and critically appraise the design and risk of bias for a planned clinical trial.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Rivera SC, Liu X, Chan AW, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. BMJ. 2020. PMID: 32907797. doi:10.1136/bmj.m3210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。